Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A laxative effect may occur in case of overdose
Established Role in Obesity Management Guidelines Semaglutide is included in major obesity management guidelines as a first-line pharmacologic option for adults with obesity or overweight and weight-related comorbidities
In the context of CBT for BED, GLP-1RAs are considered an adjunctive approach for patients with coexisting higher weight when traditional behavioral and psychological interventions alone are insufficient to manage binge-eating behaviors and support weight management
In the Phase 3 REDEFINE-1 trial, adding cagrilintide to semaglutide pushed average weight loss from 14.9% to 20.4%
Patients are encouraged to keep in close contact with their Trusta Clinic physician throughout the process
Liraglutide 3 mg produces mean weight loss of approximately 58 kg (1118 lbs)
)
/assets/images/provider/photos/2798511.png)
